Paola Lattus

$1.1 Billion Worldwide Hybrid Fiber Optic Connectors Industry to 2027 - Featuring Amphenol, Hirose Electric and LEMO Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, September 12, 2022
Technology, Networks, Audio, Video, Hardware, Traction, Dust, HD, Growth, Paola Lattus, COVID-19, Stainless steel, Industry, Electrical cable, Video game console

Hybrid fiber optic connectors combine fiber, power, and low voltage control signal in a single unit.

Key Points: 
  • Hybrid fiber optic connectors combine fiber, power, and low voltage control signal in a single unit.
  • Key Questions Answered in This Report:
    How has the global hybrid fiber optic connectors market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hybrid fiber optic connectors market?
  • What is the structure of the global hybrid fiber optic connectors market and who are the key players?

FDA Grants IDE Approval to Evaluate Attune Medical’s ensoETM in Radiofrequency Ablation Procedures

Retrieved on: 
Thursday, September 8, 2022
Research, Medical Devices, Surgery, FDA, Clinical Trials, Cardiology, Radiology, General Health, Health, Science, Lung, Santang, National, University, Catheter ablation, DRS, Hospital of the University of Pennsylvania, Doctor of Philosophy, Associate, US Foods, National Heart, Lung, and Blood Institute, Heart, Temperature, Esophagus, IDE, Electrophysiology, Food, Small Business Innovation Research, Research assistant, Paola Lattus, Hospital, SBIR, FDA, Mercer (consulting firm), Atrial fibrillation, IMPACT, NOT, Patient, Medical device, Pharmaceutical industry, Medicine, EP Europace

The US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to Attune Medical to evaluate the companys ensoETM in the reduction of esophageal thermal injury during cardiac radiofrequency ablation procedures.

Key Points: 
  • The US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to Attune Medical to evaluate the companys ensoETM in the reduction of esophageal thermal injury during cardiac radiofrequency ablation procedures.
  • Thermal injury during RF ablation procedures is a major concern in electrophysiology, commented Dr. Santangeli.
  • The data from this study will be used to expand the ensoETMs intended use in the US to include reduction of esophageal thermal injury during cardiac radiofrequency ablation procedures.
  • The ensoETM has NOT been approved or cleared by the FDA to reduce thermal injury to the esophagus during radiofrequency cardiac ablation procedures.

Raphael Hospital Implements Oosto’s Vision AI Technology to Secure Sensitive Areas and Help Keep Operating Rooms Sterile

Retrieved on: 
Thursday, September 8, 2022
Technology, Hospitals, Security, Health Technology, Software, Biometrics, Internet, Health, Artificial Intelligence, National Board of Review: Top Ten Films, Patient safety, Patient, Fortune 500, Safety, Hospital, SoftBank Group, Leonardo da Vinci, Paola Lattus, Solution, Top Ten, Sport, Qualcomm Ventures, Infection, Physician, Facial recognition, Travel, St. Raphael's Hospital, Multimedia, Medical tourism, Nursing, Mako, Efficiency, Health insurance, Online shopping, Health

( Oosto.com ) Raphael Hospital, a top private hospital in Israel, has partnered with Oosto, the worlds leading vision AI company, to provide frictionless, face-based access control to sensitive areas within its state-of-the-art facility.

Key Points: 
  • ( Oosto.com ) Raphael Hospital, a top private hospital in Israel, has partnered with Oosto, the worlds leading vision AI company, to provide frictionless, face-based access control to sensitive areas within its state-of-the-art facility.
  • Recently rebuilt from the ground up, Raphael Hospital is today world-renowned for its premium standard of patient-centered care.
  • Authorized personnel simply go through the doors without having to use keys, cards, codes, or even slowing down, said Raphael Cohen, Operating Rooms Manager.
  • To learn more about this case study, and Oostos Vision AI solutions for hospitals and healthcare settings, please visit https://oosto.com/industry/healthcare/
    Raphael Hospital is Israels finest highly technological private hospital.

Accuray Partners with Swiss-based Genolier Innovation Hub to Bring Medical and Technological Advances to Patients Faster

Retrieved on: 
Wednesday, September 7, 2022
The Retreat, Technology, Safety, Risk, Medtech, Board of directors, Health, Hub, U.S. Securities and Exchange Commission, Genolier Swiss Medical Network SA, Electron capture, Twitter, Academy of Clinical Laboratory Physicians and Scientists, Delegate, Patient, Philosophy, Time, Board, SEC, SIX Swiss Exchange, Industry, Cyberknife, Security (finance), NASDAQ, Ageing, R, Radiation, Lists of diseases, LinkedIn, Investment, Hospital, Faculty, Scientist, Clinique, Neoplasm, Private Securities Litigation Reform Act, YouTube, SWX, Heart, Education, Pharma, Paola Lattus, List of life sciences, Annual report, Ohio bioscience sector, Forward-looking statement, Pharmaceutical industry, Medical imaging, Facebook, Physician

SUNNYVALE, Calif., Sept. 7, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company is joining forces with Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA (SWX: AEVS), in support of a unique new approach to improving patient care. Genolier Innovation Hub will unite companies from the medtech, pharma and biosciences sectors, physicians and scientists, under one roof, with the goal of bringing medical and technological advances to patients faster. The Hub is expected to open in early 2024.

Key Points: 
  • Genolier Innovation Hub will unitecompanies from the medtech, pharma and biosciences sectors, physicians and scientists, under one roof, with the goal of bringing medical and technological advances to patients faster.
  • Genolier Innovation Hub will be located in the heart of the Genolier Healthcare Campus in Genolier, Switzerland.
  • "We are proud to lead the radiation therapy industry as an anchor for Genolier Innovation Hub.
  • "We look forward to partnering with Genolier Innovation Hub to usher in a new level of collaboration that speeds the progress made in patient-centric care.

Ospitek, Inc. Awarded Two Additional Patents for Innovations in Surgical Care Coordination

Retrieved on: 
Friday, September 2, 2022
Partnership, Patient, Method, CEO, Technology, HIT, SAN, Internet, Time, Entrepreneurship, United States Patent Office fire, Solution, Workflow, Hospital, Organization, OR, MIFI, Time (magazine), Paola Lattus, Wilford Hall Ambulatory Surgical Center, Communication, IP, VIEW, AI, Adoption, Health, Medicine, Medical device, IOT

SAN DIEGO,  September 02, 2022  /PRNewswire-PRWeb/ -- Ospitek Inc., a healthcare technology company delivering IoT and AI enabled solutions for hospitals, outpatient surgery centers, and surgeon offices, has been granted patents for a "System and method for live patient tracking for surgical centers and hospitals" and a "Method and apparatus for an intelligent schedule board for operating rooms for surgical centers and hospitals" from the United States Patent Office. The patents relate to the company's proprietary, IoT enabled, real-time patient pathway visualization platform called VIEW. The granted patents cover over 40 claims for different inventive features relating to Hospital and Surgical Center visualization.

Key Points: 
  • San Diego, California based Ospitek, Inc. has received additional patents for the company's proprietary IoT and AI enabled surgical coordination and visualization platform.
  • The patents relate to the company's proprietary, IoT enabled, real-time patient pathway visualization platform called VIEW.
  • The granted patents cover over 40 claims for different inventive features relating to Hospital and Surgical Center visualization.
  • Through a modular approach, the VIEW platform aligns workflows throughout the entire patient pathway; keeping care teams aligned, optimizing workflow efficiency, and improving the patient, staff, and family member experience.

xCAT IQ Installed at Hadassah University Hospital

Retrieved on: 
Thursday, September 1, 2022
Hebrew University of Jerusalem, University, IQ, Fracture, 3D, Bed, DDS, Oral, ANN, Rothschild, Eleazar Sukenik, World Zionist Organization, Oral and maxillofacial surgery, Bone fracture, CT, Hebrew language, Department, Human, Hospital, Multimedia, Cone beam computed tomography, MD, Cholesteatoma, Surgeon, High-dependency unit, Paola Lattus, School, Hadassah Medical Center, XCAT, Prophet, Street of the Prophets, MS, Otorhinolaryngology, Dentistry, Patient, Medical imaging, Health, DMD, Hadassah Women's Zionist Organization of America

Xoran's xCAT IQ is a truly mobile cone beam CT system for soft tissue and bone imaging.

Key Points: 
  • Xoran's xCAT IQ is a truly mobile cone beam CT system for soft tissue and bone imaging.
  • With high resolution down to 70 microns and an extremely small footprint, the xCAT IQ is uniquely suited to meet the needs of the Hadassah clinicians.
  • The implementation of xCAT IQ was largely facilitated by the efforts of Prof. Yoram Weiss, MD, Director General of the Hadassah Medical Organization.
  • Since the establishment of Hadassah's first hospital on Jerusalem's Neviim Street (Street of the Prophets) - a gift of the Rothschild family in 1918 - the Hadassah University Medical Center has expanded to include two University hospitals in Jerusalem - located on Mt.

Beyond Clean and U.S. Career Institute Partner to Solve Sterile Processing Employment Shortages through Education and Customized Recruiting

Retrieved on: 
Thursday, September 1, 2022
Privacy Office of the U.S. Department of Homeland Security, Program, Solution, Distance Education Accrediting Commission, Distance education, U.S. Career Institute, Infection, United States Department of Education, LinkedIn, Education, Student, Faculty, Paola Lattus, Weston Distance Learning, Inc., Certification, Central sterile services department, DEAC, Acquisition, Industry, Patient safety, Sterility, Medical device

FORT COLLINS, Colo., Sept. 1, 2022 /PRNewswire-PRWeb/ -- Beyond Clean, a leading provider of Sterile Processing education and consulting and U.S. Career Institute, an online educator, today announced the strategic initiative Beyond Clean Powered by U.S. Career Institute. This collaborative effort supports Sterile Processing departments across the U.S. in solving employment shortages through education and customized recruiting.

Key Points: 
  • Beyond Clean and U.S. Career Institute have partnered to bring Employment Solutions to Sterile Processing Departments through education and customized recruiting.
  • FORT COLLINS, Colo., Sept. 1, 2022 /PRNewswire-PRWeb/ -- Beyond Clean, a leading provider of Sterile Processing education and consulting and U.S. Career Institute, an online educator, today announced the strategic initiative Beyond Clean Powered by U.S. Career Institute.
  • This collaborative effort supports Sterile Processing departments across the U.S. in solving employment shortages through education and customized recruiting.
  • Earl Weston, Owner and President of U.S. Career Institute, stated, "Understaffed and Undertrained Sterile Processing Departments have the potential to cause disruption within our healthcare systems.

Avail Medsystems to Participate in the 2022 Wells Fargo Healthcare Conference

Retrieved on: 
Thursday, September 1, 2022
Machine learning, Silicon, Conference, Organization, Technology, Medtech, Industry, Paola Lattus, AI, Adoption, Health, Pharmaceutical industry, Medical device

SANTA CLARA, Calif., Sept. 1, 2022 /PRNewswire/ -- Avail, the digital hub of the operating room enabling the medical technology (MedTech) and healthcare industries to work smarter to advance patient care, today announced that Ryan Magnes, President of Avail, will present a corporate overview at the 2022 Wells Fargo Healthcare Conference on Thursday, September 8, 2022, at 8:35 a.m.

Key Points: 
  • SANTA CLARA, Calif., Sept. 1, 2022 /PRNewswire/ -- Avail, the digital hub of the operating room enabling the medical technology (MedTech) and healthcare industries to work smarter to advance patient care, today announced that Ryan Magnes, President of Avail, will present a corporate overview at the 2022 Wells Fargo Healthcare Conference on Thursday, September 8, 2022, at 8:35 a.m.
  • Avail enables the MedTech industry and healthcare providers to work together more often and more efficiently, harnessing expertise and technology in and out of the OR to accelerate the innovation, adoption, and reach of tools and techniques to improve patient care.
  • Today, 50 MedTech organizations have contracted with Avail to rethink commercial models, reduce inefficiencies, and enhance the reach and timeliness of collaboration.
  • Avail was founded in 2017 by MedTech veterans with a vision to leverage Silicon Valley technology expertise to evolve the industry and enable MedTech and healthcare to deliver the best care possible.

DGAP-News: Volta Medical's AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication

Retrieved on: 
Wednesday, August 31, 2022
Volta, Machine learning, EGM, CEO, Technology, JCE, Obesity, Arrhythmia, Artificial intelligence, Brain, Ageing, Entrepreneurship, AF, Catheter ablation, Heart, Business intelligence software, Heart failure, Atrial tachycardia, Electrophysiology, Physician, Stroke, Moyamoya disease, Common, Hospital, Journal, Deep learning, MD, Paola Lattus, E-GMS, Prevalence, Hypertension, FDA, Population, EV, Algorithm, Diabetes, Atrial fibrillation, Intuition, Journal of Cardiovascular Electrophysiology, Patient, Palpitations, Medical device, Medical imaging, Pharmaceutical industry, EU

The article titled Artificial Intelligence Software Standardizes Electrogram-based Ablation Outcome for Persistent Atrial Fibrillation is available at https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.15657 .

Key Points: 
  • The article titled Artificial Intelligence Software Standardizes Electrogram-based Ablation Outcome for Persistent Atrial Fibrillation is available at https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.15657 .
  • Results demonstrated that VX1 allowed for the building of standardized Volta VX1 maps, used as a reference for operators to conduct EGM-guided ablation.
  • The standardization of the detection of abnormal EGMs facilitated a robust patient-to-patient and center-to-center uniformity in EGM-based ablation.
  • Furthermore, after a one-year follow-up, patients demonstrated a high freedom from atrial fibrillation and from any atrial arrhythmia, 89% and 73% after an average of 1.3 procedures per patient, respectively.

Volta Medical’s AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication

Retrieved on: 
Wednesday, August 31, 2022
Volta, Machine learning, EGM, CEO, Technology, JCE, Obesity, Arrhythmia, Artificial intelligence, Brain, Ageing, Entrepreneurship, AF, Catheter ablation, Heart, Business intelligence software, Heart failure, Atrial tachycardia, Electrophysiology, Physician, Stroke, Moyamoya disease, Common, Hospital, Journal, Deep learning, MD, GLOBE, Paola Lattus, E-GMS, Prevalence, Hypertension, FDA, Population, EV, Algorithm, Diabetes, Atrial fibrillation, Intuition, Journal of Cardiovascular Electrophysiology, Patient, Palpitations, Medical device, Medical imaging, Pharmaceutical industry, EU

The article titled Artificial Intelligence Software Standardizes Electrogram-based Ablation Outcome for Persistent Atrial Fibrillation is available at https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.15657 .

Key Points: 
  • The article titled Artificial Intelligence Software Standardizes Electrogram-based Ablation Outcome for Persistent Atrial Fibrillation is available at https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.15657 .
  • Results demonstrated that VX1 allowed for the building of standardized Volta VX1 maps, used as a reference for operators to conduct EGM-guided ablation.
  • The standardization of the detection of abnormal EGMs facilitated a robust patient-to-patient and center-to-center uniformity in EGM-based ablation.
  • Furthermore, after a one-year follow-up, patients demonstrated a high freedom from atrial fibrillation and from any atrial arrhythmia, 89% and 73% after an average of 1.3 procedures per patient, respectively.